The Safety and Efficacy of Intravenous Anidulafungin as a Treatment for Azole-Refractory Mucosal Candidiasis (FRMC)
Clinical trial NCT00041704 · COMPLETED
Trial details
- NCT number
- NCT00041704
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-08-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.